Improving Brain Tumour Care surveys share your experiences and help create change

Category: Policy & Public Affairs

  • APPG on Brain Tumours this week

    On Wednesday 9th December the All Party Parliamentary Group (APPG) on Brain Tumours held a meeting in Westminster to discuss the new five year Independent Cancer Taskforce Strategy. The event was well attended and several MPs came along to listen to the experiences and concerns of our supporters.

  • New NICE guideline on brain tumours

    We were recently pleased to hear that the National Institute for Health and Care Excellence (NICE) will be developing a new guideline on primary brain tumours and cerebral metastases.

  • You’re invited to our APPG on brain tumours

    We would like to invite you to our meeting of the All-Party Parliamentary Group (APPG) on Brain Tumours.

  • Emergency diagnosis more likely for brain tumour patients

    Brain tumour patients are more likely to be diagnosed via a hospital A&E department than those with any other type of tumour, new figures show.

  • Off-patent Drugs Bill blocked at House of Commons

    The Off-patent Drugs Bill has been blocked at its second reading in the House of Commons despite support from MPs of both parties and a number of charities and health organisations. It will be put onto the agenda for another reading in December, however is unlikely to be allocated time for debate.

  • Young Ambassador meets Caroline Lucas MP

    One of our fantastic Young Ambassadors April Watkins recently met with Caroline Lucas, the country’s first Green Party MP in Brighton, where she was able to share details of our HeadSmart campaign and her personal experiences as a young adult going through treatment for a brain tumour.

  • Clinicians back Off-patent Drugs Bill

    The potential benefit of the Off-patent Drugs Bill to people affected by a brain tumour has been highlighted in an editorial featured in The Telegraph. The paper also features a letter in support of The Bill signed by 40 clinicians including Professor Susan Short who is leading a clinical trial to investigate the effect of hydroxychloroquine on high grade gliomas undergoing radiotherapy.

  • Our response to the Accelerated Access Review

    The interim report of the Accelerated Access Review, a UK Government review looking at ways to speed up patient access to new drugs, was published on the 27th October.

  • Latest figures reveal where people live could influence cancer diagnosis times

    Cancer Research UK have released some figures that demonstrate how getting a cancer diagnosis in a timely manner varies across the UK.

  • Northern Ireland’s first nationwide survey into cancer patient experience is published

    The Northern Ireland Cancer Patient Experience Survey contains data on the experience of 3,200 cancer patients between 2014 and 2015, including 28 patients with high-grade brain tumours.

  • Our response to new Independent Cancer Taskforce report

    On Sunday, an Independent Cancer Taskforce published its report, Achieving world class cancer outcomes: a strategy for England. This sets out 95 recommendations for the delivery of services for cancer by the NHS in England for the next five years. (Tuesday July 21).

  • Should it be a luxury to have a clinical nurse specialist?

    If you have a brain tumour, should it be a luxury to know you will always be able to talk to one person in your medical team who knows about brain tumours and – crucially – knows about your brain tumour and its impact on you?